RENORMAX Drug Patent Profile
✉ Email this page to a colleague
When do Renormax patents expire, and when can generic versions of Renormax launch?
Renormax is a drug marketed by Schering and is included in one NDA.
The generic ingredient in RENORMAX is spirapril hydrochloride. Additional details are available on the spirapril hydrochloride profile page.
Summary for RENORMAX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 32 |
Patent Applications: | 4,668 |
DailyMed Link: | RENORMAX at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for RENORMAX
US Patents and Regulatory Information for RENORMAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | RENORMAX | spirapril hydrochloride | TABLET;ORAL | 020240-001 | Dec 29, 1994 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Schering | RENORMAX | spirapril hydrochloride | TABLET;ORAL | 020240-004 | Dec 29, 1994 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Schering | RENORMAX | spirapril hydrochloride | TABLET;ORAL | 020240-002 | Dec 29, 1994 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Schering | RENORMAX | spirapril hydrochloride | TABLET;ORAL | 020240-003 | Dec 29, 1994 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for RENORMAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Schering | RENORMAX | spirapril hydrochloride | TABLET;ORAL | 020240-001 | Dec 29, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
Schering | RENORMAX | spirapril hydrochloride | TABLET;ORAL | 020240-002 | Dec 29, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
Schering | RENORMAX | spirapril hydrochloride | TABLET;ORAL | 020240-004 | Dec 29, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
Schering | RENORMAX | spirapril hydrochloride | TABLET;ORAL | 020240-003 | Dec 29, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for RENORMAX
See the table below for patents covering RENORMAX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Ireland | 812475 | ⤷ Try a Trial | |
Greece | 75059 | ⤷ Try a Trial | |
Portugal | 73861 | PROCESS FOR PREPARING CARBOXYALKYL DIPEPTIDES | ⤷ Try a Trial |
Hungary | 193146 | PROCESS FOR PRODUCTION OF /CARBOXI-ALCILE/ DIPEPTIDES | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for RENORMAX
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0050800 | 96C0028 | Belgium | ⤷ Try a Trial | PRODUCT NAME: PORFIMERE SODIQUE; NAT. REGISTRATION NO/DATE: NL 19150 19960409; FIRST REGISTRATION: NL - RVG 16652 19940411 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |